Inactive / Discontinued
LINVOSELTAMAB
UNII M3CPC50MZS
Substance Identification & Data
This profile provides standardized clinical and technical data for Linvoseltamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) M3CPC50MZS.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2408319-25-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
M3CPC50MZS
2408319-25-3
N/A
Detailed Substance Profile
Preferred Name
LINVOSELTAMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
Molecular Formula
M3CPC50MZS
The specific atomic composition represented as a molecular structure string.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12104
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
JK-13
Identifier assigned by the United States Adopted Names Council.
Substance Type
LINVOSELTAMAB
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Linvoseltamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
FDA Official Name
LINVOSELTAMAB
Linvoseltamab-GCPT
Common Names & Synonyms
Human IgG4-based anti-CD3 x anti-BCMA bispecific monoclonal antibody that binds to CD3 and BCMA
IMMUNOGLOBULIN G4 (103-CYSTEINE,108-CYSTEINE,233-PROLINE,238-PROLINE,239-VALINE,240-ALANINE,DE-241-GLYCINE), ANTI-(HUMAN B-CELL MATURATION ANTIGEN) (HUMAN MONOCLONAL REGN5458 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN5458 .KAPPA.-CHAIN, (231->230'),(234->233')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G4 (232-PROLINE,237-PROLINE,238-VALINE,239-ALANINE,DE-240-GLYCINE,439-ARGININE,440-PHENYLALANINE,449-PROLINE) ANTI-(HUMAN CD3 ANTIGEN) (HUMAN MONOCLONAL REGN5458 .GAMMA.4-CHAIN) DISULFIDE WITH HUMAN MONOCLONAL REGN5458 .KAPPA.-CHAIN
LINVOSELTAMAB [USAN]
Linvoseltamab [WHO-DD]
linvoseltamab [INN]
Brand / Trade Names
LYNOZYFIC
Technical Codes
REGN-5458
REGN5458
NDC Products Containing LINVOSELTAMAB
This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory:
